Advanced Filters
noise
Found 64,783 clinical trials
J Jennifer L Jones, MD

Evaluating the Impact of Including Virtual Dietary Education Within an Electronic Irritable Bowel Syndrome Pathway

Irritable bowel syndrome is a functional bowel disorder that affects many Canadians. The syndrome involves abdominal pain and change in frequency or form of bowel movements, and these symptoms can lead to a decreased quality of life for patients. Primary care physicians are dissatisfied with current referral processes, and patients …

18 - 65 years of age All Phase N/A
J Jill Landsbaugh Kaar, PhD

One-4-ALL Initiative

This study aims to improve health outcomes of individuals and populations, enhance the patient experience, reduce the per capita cost of care, and ensure the well-being of our healthcare providers (quadruple aim). These goals are increasingly difficult to achieve, given the challenges of changes to workflow, staffing shortages, and increased …

18 - 99 years of age All Phase N/A
R Rui Abrunhosa Gonçalves, Phd

Intervention Program With Perpetrators of Intimate Partner Violence

The current project aims to develop, implement and assess the effectiveness of an intervention program for perpetrators of intimate partner violence (both volunteers and court-mandated) that incorporates Motivational Interviewing techniques (MIT) as well as cognitive-behavioral and psychoeducational strategies implemented in a community setting. The intervention focuses on ending violence against …

18 - 70 years of age Male Phase N/A
T Ting Chang

Open-Label Extension of Tocilizumab in Subjects With Generalized Myasthenia Gravis

To evaluate the safety and efficacy of tocilizumab in the treatment of generalized myasthenia gravis (gMG) as an extension study for the participants who previously completed Study tMG(NCT05067348).

18 - 80 years of age All Phase 2/3

A Clinical Study of MIL95 in Advanced Malignancies.

This study is composed of two stages: Part A initial dose escalation and Part B maintenance dose escalation. Both parts will adopt the classical 3+3 dose escalation design. The starting dose for phase Ia part A is 0.1 mg/kg QW, followed by 3 dose cohorts (0.3mg/kg QW, 0.8mg/kg QW and …

18 years of age All Phase 1

Autologous Ex-vivo Gene Modified HSCT in MPSII

Patients with MPS II have a clinical disorder marked by progressive brain disease, neurological and somatic symptoms due to the accumulation of undigested glycosaminoglycans in all cells of the body. This study will be the first in human clinical trial to explore the safety, tolerability and clinical efficacy of ex …

3 - 12 years of age Male Phase 1/2
S Sang Yeoup Lee, MD

Effect of Fermented Protaetia Brevitarsis Seulensis Powder on Alcohol-induced Liver Disease

The investigators conduct a randomized, double-blind, placebo-controlled study to investigate the effects of Fermented Protaetia brevitarsis seulensis powder on Alcohol-induced Liver Disease in adults for 8 weeks.

19 years of age All Phase N/A
M Marinelle Nunez, B.S.

The Effects of Dietary Erythritol on Platelet Reactivity and Vascular Inflammation

The purpose is to conduct a dietary intervention study in which human participants will consume beverages sweetened with erythritol or aspartame, each for 2 weeks, in a randomized crossover design

18 - 70 years of age All Phase N/A
H Helmut Salih, Prof. Dr.

FusionVAC22_01: Fusion Transcript-based Peptide Vaccine Combined With Immune Checkpoint Inhibition

The aim of this clinical trial is to evaluate the immunogenicity along with safety and toxicity as well as first efficacy of a DNAJB1-PRKACA fusion transcript-based peptide vaccine (Fusion-VAC-XS15) in combination with anti-programmed cell death-ligand 1 immune checkpoint inhibition (ICI) by Atezolizumab (TecentriqTM) in patients with Fibrolamellar hepatocellular carcinoma (FL-HCC) …

18 years of age All Phase 1

Alveolar Macrophage Programming Following Endotoxin Exposure

The histologic hallmarks of lung inflammation include accumulation of inflammatory cells in the airspaces and interstitium, injury to alveolar epithelial and endothelial cells, loss of epithelial-capillary integrity and accumulation of edema fluid in the interstitium and airspaces. Accordingly, for alveolar repair to occur inflammation must be halted, debris and inflammatory …

18 - 50 years of age All Phase N/A

Simplify language using AI